{"nct_id":"NCT00446602","title":"A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)","status":"WITHDRAWN","status_verified_date":"2011-06","start_date":null,"start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2009-08","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JNJ"]}